Work:
Epic Therapeutics/Baxter Healthcare
Apr 2005 - Jul 2010
-
Research Scientist I
U.S. Genomics Inc.
Jul 2001 - Mar 2005
-
Research Scientist II
Ontogeny/Curis
Oct 1997 - Jul 2001
-
Senior Research Associate
Genetics Institute/Wyeth
1991 - 1996
-
Research Associate
Education:
University of Massachusetts, Amherst 1987
B.S., Microbiology
Honor & Awards:
• M.V. Gallo. 2009. A paragon of high quality contributions and consistency. Baxter’s Technology Resources Division Role Model Award.
• L. Brown, R. Fortier, M.V. Gallo, M. Ganley, K. Wood, K. Saintcry, K. Hogeland, T. Jeannotte and K.A. Gillis. 2009. PROMAXX antisense oligonucleotide microspheres reverse autoimmune diabetes. Baxter Corporate Technical Award for Outstanding Innovation.
• L. Brown, R. Fortier, M.V. Gallo, M. Ganley, K. Wood, K. Saintcry, K. Hogeland, J. Knox, D. Lafreniere, T. Jeannotte and K.A. Gillis. 2009. Fabrication & Characterization of Antisense Oligonucleotide Microspheres (ASO-MS) for the reversal of Type 1 diabetes; murine and human ASO-formulations. Baxter’s Tech. Resources Division Ingenuity Award.
• L. Brown, M.V. Gallo, K.A. Gillis, K. Hogeland, J. Knox, D. Lafreniere, and T. Scott. 2006. PROMAXX nucleic acid microspheres for type 1 diabetes intervention. Baxter’s Medication Delivery Technology & Teamwork (TnT) Award.